Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Schram

Showing results (51-60 of 186) with videos related to

Pageof 19
Sort By:
Ophthalmology. Retina|June 8, 2021
Clinical and Morphologic Characteristics of Extracellular Signal-Regulated Kinase Inhibitor-Associated RetinopathyJasmine H Francis, Julia Canestraro, Dianna Haggag-Lindgren, et al.
The Oncologist|August 2, 2023
A Phase I Dose-Escalation Study of LY3405105, a Covalent Inhibitor of Cyclin-Dependent Kinase 7, Administered to Patients With Advanced Solid TumorsElena Garralda, Alison M Schram, Philippe L Bedard, et al.
JCO Precision Oncology|June 21, 2019
Genomic Heterogeneity Underlies Mixed Response to Tropomyosin Receptor Kinase Inhibition in Recurrent GliomaA M Schram, P Jonsson, A Drilon, et al.
Cancer Discovery|December 2, 2025
Reflections on Advances in Cancer Research in 2025Elsa Bernard, Isidro Cortés-Ciriano, Federico Gaiti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 30, 2020
Enrichment of kinase fusions in ESR1 wild-type, metastatic breast cancer revealed by a systematic analysis of 4854 patientsD S Ross, B Liu, A M Schram, et al.
Journal of the National Cancer Institute|December 14, 2025
NRG1 fusion-positive solid tumors: clinical detection, genomic landscape, and real-world data in pancreatic cancerAlison M Schram, Soo-Ryum Yang, Genessa Kahn, et al.
JAMA Ophthalmology|September 2, 2021
Clinical and Morphologic Characteristics of Fibroblast Growth Factor Receptor Inhibitor-Associated RetinopathyJasmine H Francis, James J Harding, Alison M Schram, et al.
Nature Genetics|March 17, 2009
A germline JAK2 SNP is associated with predisposition to the development of JAK2(V617F)-positive myeloproliferative neoplasmsOuti Kilpivaara, Semanti Mukherjee, Alison M Schram, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 25, 2019
TRK Fusions Are Enriched in Cancers with Uncommon Histologies and the Absence of Canonical Driver MutationsEzra Y Rosen, Debra A Goldman, Jaclyn F Hechtman, et al.
Biorxiv : the Preprint Server for Biology|February 23, 2026
Coexistent <i>PTEN</i> and <i>PIK3CA</i> alterations hyperactivate mTORC1 signaling in endometrial cancers and cause their selective sensitivity to mTORC1 inhibitionHilla Solomon, Radha Mukherjee, Yu Chi Yang, et al.
Pageof 19

Showing results (51-60 of 186) with videos related to

Sort By:
Pageof 19
Ophthalmology. Retina|June 8, 2021
Clinical and Morphologic Characteristics of Extracellular Signal-Regulated Kinase Inhibitor-Associated RetinopathyJasmine H Francis, Julia Canestraro, Dianna Haggag-Lindgren, et al.
The Oncologist|August 2, 2023
A Phase I Dose-Escalation Study of LY3405105, a Covalent Inhibitor of Cyclin-Dependent Kinase 7, Administered to Patients With Advanced Solid TumorsElena Garralda, Alison M Schram, Philippe L Bedard, et al.
JCO Precision Oncology|June 21, 2019
Genomic Heterogeneity Underlies Mixed Response to Tropomyosin Receptor Kinase Inhibition in Recurrent GliomaA M Schram, P Jonsson, A Drilon, et al.
Cancer Discovery|December 2, 2025
Reflections on Advances in Cancer Research in 2025Elsa Bernard, Isidro Cortés-Ciriano, Federico Gaiti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 30, 2020
Enrichment of kinase fusions in ESR1 wild-type, metastatic breast cancer revealed by a systematic analysis of 4854 patientsD S Ross, B Liu, A M Schram, et al.
Journal of the National Cancer Institute|December 14, 2025
NRG1 fusion-positive solid tumors: clinical detection, genomic landscape, and real-world data in pancreatic cancerAlison M Schram, Soo-Ryum Yang, Genessa Kahn, et al.
JAMA Ophthalmology|September 2, 2021
Clinical and Morphologic Characteristics of Fibroblast Growth Factor Receptor Inhibitor-Associated RetinopathyJasmine H Francis, James J Harding, Alison M Schram, et al.
Nature Genetics|March 17, 2009
A germline JAK2 SNP is associated with predisposition to the development of JAK2(V617F)-positive myeloproliferative neoplasmsOuti Kilpivaara, Semanti Mukherjee, Alison M Schram, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 25, 2019
TRK Fusions Are Enriched in Cancers with Uncommon Histologies and the Absence of Canonical Driver MutationsEzra Y Rosen, Debra A Goldman, Jaclyn F Hechtman, et al.
Biorxiv : the Preprint Server for Biology|February 23, 2026
Coexistent <i>PTEN</i> and <i>PIK3CA</i> alterations hyperactivate mTORC1 signaling in endometrial cancers and cause their selective sensitivity to mTORC1 inhibitionHilla Solomon, Radha Mukherjee, Yu Chi Yang, et al.
Pageof 19